S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom

MyMD Pharmaceuticals (MYMD) Insider Trading & Ownership

$2.25
+0.15 (+7.14%)
(As of 04/17/2024 ET)

MyMD Pharmaceuticals (NASDAQ:MYMD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
2.63%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$166,500.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get MYMD Insider Trade Alerts

Want to know when executives and insiders are buying or selling MyMD Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

MYMD Insider Buying and Selling by Quarter

MyMD Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/24/2023Paul RivardInsiderBuy5,000$33.30$166,500.00  
(Data available from 1/1/2013 forward)

MYMD Insider Trading Activity - Frequently Asked Questions

Who is on MyMD Pharmaceuticals's Insider Roster?

The list of insiders at MyMD Pharmaceuticals includes Joshua Silverman, and Paul Rivard. Learn more on insiders at MYMD.

What percentage of MyMD Pharmaceuticals stock is owned by insiders?

2.63% of MyMD Pharmaceuticals stock is owned by insiders. Learn more on MYMD's insider holdings.

Which MyMD Pharmaceuticals insiders have been buying company stock?

The following insider purchased MYMD shares in the last 24 months: Paul Rivard ($181,784.70).

How much insider buying is happening at MyMD Pharmaceuticals?

Insiders have purchased a total of 5,333 MYMD shares in the last 24 months for a total of $181,784.70 bought.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:MYMD) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners